WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nicole R. HadasSVP Chief Legal Officer2024-02-295,974$1.58
$9.44kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-297,169$1.58
$11.33kSell
John P. ButlerCEO and President2024-02-2946,570$1.58
$73.58kSell
Michel DahanSVP Chief Operating Officer2024-02-298,661$1.58
$13.68kSell
Nicole R. HadasSVP Chief Legal Officer2024-02-277,411$1.52
$11.26kSell
John P. ButlerCEO and President2024-02-2737,733$1.52
$57.35kSell
Michel DahanSVP Chief Operating Officer2024-02-2710,744$1.52
$16.33kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-278,367$1.52
$12.72kSell
John P. ButlerCEO and President2024-02-0146,489$1.68
$78.10kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-0124,311$1.68
$40.84kSell

1 of 2

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alerce Investment Management LP7.74%16,205,119$22.20MInstitution
Vanguard Group Inc3.63%7,607,472$10.42MInstitution
Acadian Asset Management LLC3.30%6,915,503$9.47MInstitution
Muneer A. Satter2.41%5,039,602$6.90MInsider
Renaissance Technologies LLC2.28%4,779,383$6.55MInstitution
Novartis Bioventures Ltd1.63%3,405,764$4.67MInsider
Blackrock Inc1.49%3,122,824$4.28MInstitution
John P. Butler1.41%2,942,080$4.03MInsider
Millennium Management LLC1.24%2,599,987$3.56MInstitution
Susquehanna International Group LLP1.03%2,159,364$2.96MInstitution

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA26.15%8.85%Net SellingNet Selling
NBTX19.67%0.00%
AVXL31.49%5.04%Net BuyingNet Buying
VRCA41.10%58.90%Net Buying
GLUE24.82%75.18%
View Top Biotech Stocks

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 26.15% institutional shareholders, 8.85% Akebia Therapeutics insiders, and 65.00% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 2.41% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $6.70M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.